189 related articles for article (PubMed ID: 33912731)
1. A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay.
Lei RY; Carter DL; Antell AG; Nowels MA; Tole SP; Bennett JP; Turner M; Baehner FL; Leonard CE
Adv Radiat Oncol; 2021; 6(2):100607. PubMed ID: 33912731
[TBL] [Abstract][Full Text] [Related]
2. Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.
Hashiba KA; Bahl M
Breast Cancer Res Treat; 2023 Nov; 202(1):185-190. PubMed ID: 37518825
[TBL] [Abstract][Full Text] [Related]
3. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Solin LJ; Gray R; Baehner FL; Butler SM; Hughes LL; Yoshizawa C; Cherbavaz DB; Shak S; Page DL; Sledge GW; Davidson NE; Ingle JN; Perez EA; Wood WC; Sparano JA; Badve S
J Natl Cancer Inst; 2013 May; 105(10):701-10. PubMed ID: 23641039
[TBL] [Abstract][Full Text] [Related]
4. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Solin LJ; Gray R; Hughes LL; Wood WC; Lowen MA; Badve SS; Baehner FL; Ingle JN; Perez EA; Recht A; Sparano JA; Davidson NE
J Clin Oncol; 2015 Nov; 33(33):3938-44. PubMed ID: 26371148
[TBL] [Abstract][Full Text] [Related]
5. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
Sweldens C; Peeters S; van Limbergen E; Janssen H; Laenen A; Patil S; Van Zee KJ; Weltens C
Cancer J; 2014; 20(1):1-7. PubMed ID: 24445756
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score.
Van Zee KJ; Zabor EC; Di Donato R; Harmon B; Fox J; Morrow M; Cody HS; Fineberg SA
Ann Surg Oncol; 2019 Oct; 26(10):3282-3288. PubMed ID: 31342373
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.
Raldow AC; Sher D; Chen AB; Recht A; Punglia RS
J Clin Oncol; 2016 Nov; 34(33):3963-3968. PubMed ID: 27621393
[TBL] [Abstract][Full Text] [Related]
9. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
10. Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study.
Wright JL; Gray R; Rahbar H; Comstock CE; Tjoe JA; Badve S; Recht A; Sparano JA; Davidson NE; Wolff AC
NPJ Breast Cancer; 2024 Feb; 10(1):16. PubMed ID: 38396024
[TBL] [Abstract][Full Text] [Related]
11. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
Wang F; Li H; Tan PH; Chua ET; Yeo RM; Lim FL; Kim SW; Tan DY; Wong FY
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):684-91. PubMed ID: 25194727
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Yi M; Meric-Bernstam F; Kuerer HM; Mittendorf EA; Bedrosian I; Lucci A; Hwang RF; Crow JR; Luo S; Hunt KK
J Clin Oncol; 2012 Feb; 30(6):600-7. PubMed ID: 22253459
[TBL] [Abstract][Full Text] [Related]
13. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S502-8. PubMed ID: 26059650
[TBL] [Abstract][Full Text] [Related]
14. DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
Rakovitch E; Parpia S; Koch A; Grimard L; Soliman H; Stevens C; Perera F; Kong I; Senthelal S; Anthes M; Wiebe E; Cao J; Goldberg M; Smith S; Spadafora L; Whelan TJ
Breast Cancer Res Treat; 2021 Jul; 188(1):133-139. PubMed ID: 33830392
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.
Yang L; Lu D; Lai Y; Shen M; Yu Q; Lei T; Pu T; Bu H
Ann Surg Oncol; 2021 Feb; 28(2):975-984. PubMed ID: 32794031
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram.
Oses G; Mension E; Pumarola C; Castillo H; Francesc L; Torras I; Cebrecos I; Caparrós X; Ganau S; Ubeda B; Bargallo X; González B; Sanfeliu E; Vidal-Sicart S; Moreno R; Muñoz M; Santamaría G; Mollà M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190320
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
Manders JB; Kuerer HM; Smith BD; McCluskey C; Farrar WB; Frazier TG; Li L; Leonard CE; Carter DL; Chawla S; Medeiros LE; Guenther JM; Castellini LE; Buchholz DJ; Mamounas EP; Wapnir IL; Horst KC; Chagpar A; Evans SB; Riker AI; Vali FS; Solin LJ; Jablon L; Recht A; Sharma R; Lu R; Sing AP; Hwang ES; White J;
Ann Surg Oncol; 2017 Mar; 24(3):660-668. PubMed ID: 27704370
[TBL] [Abstract][Full Text] [Related]
18. Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions.
Lin CY; Mooney K; Choy W; Yang SR; Barry-Holson K; Horst K; Wapnir I; Allison K
Mod Pathol; 2018 Apr; 31(4):562-568. PubMed ID: 29243740
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy after DCIS: Useful for whom?
Karlsson P
Breast; 2017 Aug; 34 Suppl 1():S43-S46. PubMed ID: 28663003
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial.
Thorat MA; Levey PM; Jones JL; Pinder SE; Bundred NJ; Fentiman IS; Cuzick J
Clin Cancer Res; 2021 Oct; 27(19):5317-5324. PubMed ID: 34380636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
